Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  gp100:209-217(210M) peptide vaccine
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 16 and over
Trial IDs: MCC-15651, NCI-2011-00737, CDR0000682183, NCI-P8316, P-8316, 8316, NCT01176474
Start Over